Annual Accounts Receivable
$61.22 M
-$25.04 M-29.03%
31 December 2023
Summary:
NovoCure Limited annual accounts receivable is currently $61.22 million, with the most recent change of -$25.04 million (-29.03%) on 31 December 2023. During the last 3 years, it has fallen by -$35.48 million (-36.69%). NVCR annual accounts receivable is now -36.69% below its all-time high of $96.70 million, reached on 31 December 2020.NVCR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$61.32 M
+$1.45 M+2.42%
30 September 2024
Summary:
NovoCure Limited quarterly accounts receivable is currently $61.32 million, with the most recent change of +$1.45 million (+2.42%) on 30 September 2024. Over the past year, it has dropped by -$3.82 million (-5.86%). NVCR quarterly accounts receivable is now -39.27% below its all-time high of $100.97 million, reached on 31 March 2022.NVCR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.0% | -5.9% |
| 3 y3 years | -36.7% | -34.9% |
| 5 y5 years | +67.6% | +22.9% |
NVCR Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.7% | at low | -39.3% | +2.4% |
| 5 y | 5 years | -36.7% | +67.6% | -39.3% | +22.9% |
| alltime | all time | -36.7% | -39.3% |
NovoCure Limited Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $61.32 M(+2.4%) |
| June 2024 | - | $59.87 M(-0.9%) |
| Mar 2024 | - | $60.40 M(-1.3%) |
| Dec 2023 | $61.22 M(-29.0%) | $61.22 M(-6.0%) |
| Sept 2023 | - | $65.13 M(-8.2%) |
| June 2023 | - | $70.99 M(-5.1%) |
| Mar 2023 | - | $74.83 M(-13.3%) |
| Dec 2022 | $86.26 M(-7.8%) | $86.26 M(-1.5%) |
| Sept 2022 | - | $87.55 M(-10.3%) |
| June 2022 | - | $97.56 M(-3.4%) |
| Mar 2022 | - | $100.97 M(+7.9%) |
| Dec 2021 | $93.57 M(-3.2%) | $93.57 M(-0.6%) |
| Sept 2021 | - | $94.13 M(+4.1%) |
| June 2021 | - | $90.44 M(-2.2%) |
| Mar 2021 | - | $92.51 M(-4.3%) |
| Dec 2020 | $96.70 M | $96.70 M(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $84.56 M(+11.2%) |
| June 2020 | - | $76.03 M(+16.7%) |
| Mar 2020 | - | $65.14 M(+10.7%) |
| Dec 2019 | $58.86 M(+61.2%) | $58.86 M(+17.9%) |
| Sept 2019 | - | $49.90 M(+17.3%) |
| June 2019 | - | $42.53 M(+8.4%) |
| Mar 2019 | - | $39.22 M(+7.4%) |
| Dec 2018 | $36.52 M(+23.5%) | $36.52 M(+3.2%) |
| Sept 2018 | - | $35.39 M(-6.0%) |
| June 2018 | - | $37.64 M(+10.6%) |
| Mar 2018 | - | $34.04 M(+15.1%) |
| Dec 2017 | $29.57 M(+366.4%) | $29.57 M(+28.6%) |
| Sept 2017 | - | $23.00 M(+65.6%) |
| June 2017 | - | $13.89 M(+17.4%) |
| Mar 2017 | - | $11.82 M(+86.5%) |
| Dec 2016 | $6.34 M(>+9900.0%) | $6.34 M(>+9900.0%) |
| Dec 2015 | $0.00 | $0.00 |
FAQ
- What is NovoCure Limited annual accounts receivable?
- What is the all time high annual accounts receivable for NovoCure Limited?
- What is NovoCure Limited annual accounts receivable year-on-year change?
- What is NovoCure Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for NovoCure Limited?
- What is NovoCure Limited quarterly accounts receivable year-on-year change?
What is NovoCure Limited annual accounts receivable?
The current annual accounts receivable of NVCR is $61.22 M
What is the all time high annual accounts receivable for NovoCure Limited?
NovoCure Limited all-time high annual accounts receivable is $96.70 M
What is NovoCure Limited annual accounts receivable year-on-year change?
Over the past year, NVCR annual accounts receivable has changed by -$25.04 M (-29.03%)
What is NovoCure Limited quarterly accounts receivable?
The current quarterly accounts receivable of NVCR is $61.32 M
What is the all time high quarterly accounts receivable for NovoCure Limited?
NovoCure Limited all-time high quarterly accounts receivable is $100.97 M
What is NovoCure Limited quarterly accounts receivable year-on-year change?
Over the past year, NVCR quarterly accounts receivable has changed by -$3.82 M (-5.86%)